Start free

Aldeyra Therapeutics, Inc. (ALDX) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 16, 2026.

Filings shown
11
Open-market buys
4
Open-market sells
0
Buys, 10b5-1 box not checked
4 of 4

Counts cover the 11 most recent Form 4 filings Tradune holds for ALDX (filed Jun 5 – Nov 16, 2026); the score below covers only the trailing 90 days (3 buys, 0 sells). SEC EDGAR Form 4 filings for ALDX last checked Nov 21, 2026, 09:00 UTC; the latest ALDX filing Tradune holds was filed Nov 16, 2026. This is not guaranteed to be the complete record — see ALDX's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 3 filings Tradune holds for ALDX filed Nov 13 – Nov 16, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Richard DouglasDirector 1 0 200,000 — +$128,900
Michael AlfieriPrincipal Financial Officer 1 0 10,000 — +$6,500
Darlene M. Deptula-HicksDirector 1 0 7,500 — +$4,875

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

100/ 100

Purchase cluster incl. officer
3 distinct buyers3 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

ALDX appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Nov 17, 2026
    3 insiders buying · $140,275 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ALDX

Insiders reported 4 open-market purchases of ALDX between Jun 5, 2026 and Nov 16, 2026, across 4 distinct buyers. The most recent purchase was reported by Darlene M. Deptula-Hicks (Director) on Nov 12, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Darlene M. Deptula-Hicks Director · filed Nov 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 7,500 $0.65 7,500 — Nov 12, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Michael Alfieri Principal Financial Officer · filed Nov 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,000 $0.65 17,500 +133% Nov 11, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Richard Douglas Director · filed Nov 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 200,000 $0.64 395,000 +103% Nov 11, 2026
Nancy Miller-Rich Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 70,000 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 3,318 — — — Jun 9, 2026
Richard Douglas Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 70,000 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 19,909 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 2,323 — — — Jun 9, 2026
Gary M. Phillips Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 70,000 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 6,636 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 4,977 — — — Jun 9, 2026
William D. Clark Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 70,000 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 2,323 — — — Jun 9, 2026
Neal Walker Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 70,000 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 3,318 — — — Jun 9, 2026
Ben Bronstein Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 70,000 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 5,309 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 4,977 — — — Jun 9, 2026
Darlene M. Deptula-Hicks Director · filed Jun 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 84,557 — — — Jun 9, 2026
Grant / award Stock Option (Right to Buy) 9,756 — — — Jun 9, 2026
Todd C. Brady President and CEO · filed Jun 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 250,000 $1.67 1,721,298 +17% Jun 3, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ALDX's (Nov 16, 2026).

Frequently asked about ALDX insider activity

How many insiders bought ALDX stock in these Form 4 filings?

4 distinct insiders at Aldeyra Therapeutics, Inc. reported 4 open-market purchases (Form 4 code P) of ALDX shares between Jun 5, 2026 and Nov 16, 2026, the most recent filed by Darlene M. Deptula-Hicks (Director) on Nov 12, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for ALDX?

The most recent Form 4 on this page was filed by Darlene M. Deptula-Hicks (Director) on Nov 16, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ALDX insider purchase shown?

The largest open-market purchase among the filings shown was 250,000 ALDX shares at $1.67 (about $418,450) by Todd C. Brady (President and CEO) on Jun 3, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent ALDX insider purchases have the Form 4 10b5-1 box checked?

No. All 4 ALDX open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Darlene M. Deptula-Hicks (Director) on Nov 12, 2026, 7,500 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ALDX — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.